We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GE Sees ‘Quality Dividend’ From FDA Consent Decree
GE Sees ‘Quality Dividend’ From FDA Consent Decree
July 25, 2008
GE Healthcare’s efforts to remediate production issues under a consent decree for its surgical imaging business have resulted in more efficient manufacturing operations and improved product quality, a company executive says.